Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.
| Market Capitalization | $110.1012 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | 0.069 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.07 |
| EBITDA | -5,836.071 |
| Profit Margin | -1.9417 |
| Operating Margin TTM | -2.0011 |
| Return on Assets TTM | -0.5143 |
| Return on Equity TTM | -1.0641 |
| Revenue TTM | 3,181.036 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2012-06-30 | 593 | 11 | ||
| 2013-06-30 | 683 | 66 | ||
| 2014-06-30 | 476 | 16 | 733.377 | 1,343.255 |
| 2015-06-30 | 608.394 | 326.225 | 608.394 | 1,484.353 |
| 2016-06-30 | 816.845 | 399.751 | 816.845 | 2,725.341 |
| 2017-06-30 | 925.357 | 578.73 | 925.357 | -6,463.981 |
| 2018-06-30 | 1,176.457 | 674.703 | 1,176.457 | 3,524.135 |
| 2019-06-30 | 1,468.076 | 810.395 | 1,468.076 | 4,538.127 |
| 2020-06-30 | 1,423.07 | 1,423.07 | 4,737.032 | |
| 2021-06-30 | 1,310.824 | 1,310.824 | 5,818.417 | |
| 2022-06-30 | 1,489.323 | 1,489.323 | 8,407.485 | |
| 2023-06-30 | 730.34 | 730.34 | 9,546.636 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2014-06-30 | 4,955.067 | 5,234.394 | 293.695 | 15.035 | 442 | 6,189.28 |
| 2015-06-30 | 2,004.974 | 2,532.298 | 727.013 | 441.891 | 441.891 | 4,044.18 |
| 2016-06-30 | 582.256 | 1,622.587 | 831.169 | 441.891 | 441.891 | 4,048.816 |
| 2017-06-30 | 775.14 | 2,889.179 | 1,279.304 | 219.239 | 366.392 | 5,935.036 |
| 2018-06-30 | 2,316.781 | 5,494.69 | 818.305 | 147.5 | 165 | 10,369.887 |
| 2019-06-30 | 1,511.43 | 3,620.895 | 634.593 | 146.591 | 0 | 10,537.267 |
| 2020-06-30 | 2,365.022 | 5,554.72 | 1,116.819 | 63.799 | 13,391.543 | |
| 2021-06-30 | 5,604.834 | 8,599.611 | 990.189 | 69.046 | 19,095.227 | |
| 2022-06-30 | 2,111.514 | 5,396.118 | 2,002.276 | 0 | 19,340.914 | |
| 2023-06-30 | 6,027.315 | 10,075.379 | 1,752.123 | 30.541 | 30,180.264 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2014-06-30 | -246.527 | -325.718 | 43.771 | 35.971 | ||
| 2015-06-30 | -1,149.202 | -677.26 | 1,969.003 | 35.971 | 2,004.974 | |
| 2016-06-30 | -1,328.456 | -1,509.25 | -1,422.718 | 2,004.974 | 582.256 | |
| 2017-06-30 | -916.475 | -1,470.852 | 192.884 | 582.256 | 775.14 | |
| 2018-06-30 | -1,440.108 | -1,083.877 | 1,541.641 | 775.14 | 2,316.781 | |
| 2019-06-30 | -2,080.275 | -1,667.009 | -805.351 | 2,316.781 | 1,511.43 | |
| 2020-06-30 | -1,743.77 | -384.508 | 853.592 | 1,511.43 | 2,365.022 | |
| 2021-06-30 | -2,859.663 | -2,209.073 | 3,239.812 | 2,365.022 | 5,604.834 | |
| 2022-06-30 | -4,973.406 | -4,556.545 | -3,493.32 | 5,604.834 | 2,111.514 | |
| 2023-06-30 | -6,234.31 | -5,692.91 | 3,915.801 | 2,111.514 | 6,027.315 |